Evaluation of the effectiveness of phenylephrine in hypotension management in anesthesia for cardiac surgery using extracorporeal circulation

Tuan Anh Pham1, Tran Thuy Nguyen
1 E hospital's Cardiovascular Center

Main Article Content

Abstract

Background: Phenylephrine is a vasoconstrictor often chosen to raise blood pressure during induction of anesthesia. The study aimed to evaluate the effectiveness of phenylephrine in hypotension treatment in anesthesia for cardiac surgery using extracorporeal circulation.


Methods: Descriptive study and evaluation of phenylephrine response in 40 cardiac surgery patients using extracorporeal circulation.


Results: During the induction phase, phenylephrine increased mean arterial blood pressure the most at time T2 (mean mean ∆BP was 26.2 ± 6.9), then the trend gradually decreased and remained within normal limits (p<0.05). The mean number of intravenous injections of phenylephrine during the induction period was 1.1 ± 0.3 times, the mean dose of phenylephrine used was 0.9 ± 0.3 µg/kg. During the extracorporeal circulation phase, phenylephrine increased mean blood pressure early, and persistently, peaking at T5 (mean ∆HATB of 17.4 ± 3.6 mmHg). The mean number of intravenous injections of phenylephrine during the extracorporeal circulation phase was 1 time, the mean dose of phenylephrine used was 0.8 ± 0.3 µg/kg.


Conclusion: Phenylephrine is used effectively with a small number of injections and a moderate dose when treating hypotension in anesthesia for cardiac surgery using extracorporeal circulation.

Article Details

References

1. Mebazaa, A. A. Pitsis, A. Rudiger et al (2010). Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care, 14(2), 201.
2. R. J. Gordon, M. Ravin, G. R. Daicoff et al (1975). Effects of hemodilution on hypotention during cardiopulmonary bypass. Anesth Analg, 54(4), 482-488.
3. C. McGaw, M. Scarlett, R. Irvine et al (2007). Vasopressin for refractory hypotension during cardiopulmonary bypass. West Indian Medical Journal, 56, 550-554.
4. D. L. Reich, S. Hossain, M. Krol et al (2005). Predictors of hypotension after induction of general anesthesia. Anesth Analg, 101(3), 622-628, table of contents.
5. A. W. Goertz, K. H. Lindner, C. Seefelder et al (1993). Effect of phenylephrine bolus administration on global left ventricular function in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology, 78(5), 834-841.
6. A. F. Kalmar, S. Allaert, P. Pletinckx et al (2018). Phenylephrine increases cardiac output by raising cardiac preload in patients with anesthesia induced hypotension. J Clin Monit Comput.
7. J. A. DiNardo, A. Bert, M. J. Schwartz et al (1991). Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein grafts in man. J Thorac Cardiovasc Surg, 102(5), 730-735.
8. M. A. Levin, H. M. Lin, J. G. Castillo et al (2009). Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation, 120(17), 1664-1671.
9. S. Maier, W. R. Hasibeder, C. Hengl et al (2009). Effects of phenylephrine on the sublingual microcirculation during cardiopulmonary bypass. Br J Anaesth, 102(4), 485-491.
10. Y. L. Kwak, C. S. Lee, Y. H. Park et al (2002). The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*. Anaesthesia, 57(1), 9-14.